Association and interaction of APOA5, BUD13, CETP, LIPA and health-related behavior with metabolic syndrome in a Taiwanese population

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Lin, Eugene ^a,b,c   Kuo, Po Hsiu ^d   Liu, Yu Li ^e   Yang, Albert C ^f,g   Kao, Chung Feng ^h   Tsai, Shih Jen ^f,g  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b VITA GENOMICS INC   (Taiwan)

^c TickleFish Systems Corporation   (United States)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^f TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^g NATIONAL YANG MING UNIVERSITY   (Taiwan)

^h NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

APOA5 PROTEIN, HUMAN; APOLIPOPROTEIN A5; BUD13 HOMOLOG PROTEIN, HUMAN; CETP PROTEIN, HUMAN; CHOLESTEROL ESTER TRANSFER PROTEIN; CHOLESTEROL ESTERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPA PROTEIN, HUMAN; RNA BINDING PROTEIN;

ADULT; FEMALE; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE ENVIRONMENT INTERACTION; HEALTHY LIFESTYLE; HUMAN; MALE; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; PROCEDURES; SINGLE NUCLEOTIDE POLYMORPHISM; TAIWAN; WAIST CIRCUMFERENCE;

ADULT; APOLIPOPROTEIN A-V; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, HDL; FEMALE; GENE-ENVIRONMENT INTERACTION; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HEALTHY LIFESTYLE; HUMANS; MALE; METABOLIC SYNDROME; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA-BINDING PROTEINS; STEROL ESTERASE; TAIWAN; WAIST CIRCUMFERENCE;

EID: 84995380214     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep36830     Document Type: Article

References (46)

1. Tan, C. E., Ma, S., Wai, D., Chew, S. K. & Tai, E. S. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care 27, 1182-1186 (2004).
2. Kaur, J. A comprehensive review on metabolic syndrome. Cardiol. Res. Pract. 2014, 943162 (2014).
3. Prasad, H., Ryan, D. A., Celzo, M. F. & Stapleton, D. Metabolic syndrome: definition and therapeutic implications. Postgrad. Med. 124, 21-30 (2012).
4. Povel, C. M., Boer, J. M., Reiling, E. & Feskens, E. J. Genetic variants and the metabolic syndrome: A systematic review. Obes. Rev. 12, 952-967 (2011).
5. Maász, A. et al. Apolipoprotein A5 T-1131C variant confers risk for metabolic syndrome. Pathol. Oncol. Res. 13, 243-247 (2007).
6. Yamada, Y. et al. Prediction of genetic risk for metabolic syndrome. Atherosclerosis 191, 298-304 (2007).
7. Hsu, L. A. et al. Apolipoprotein A5 gene-1131T/C polymorphism is associated with the risk of metabolic syndrome in ethnic Chinese in Taiwan. Clin. Chem. Lab. Med. 46, 1714-1719 (2008).
8. Ong, K. L. et al. Association of a genetic variant in the apolipoprotein A5 gene with the metabolic syndrome in Chinese. Clin. Endocrinol. (Oxf). 74, 206-213 (2011).
9. Xu, C. et al. Effects of APOA5-1131T> C (rs662799) on fasting plasma lipids and risk of metabolic syndrome: evidence from a casecontrol study in China and a meta-analysis. PLoS One 8, e56216 (2013).
10. Kim, Y. R. & Hong, S. H. Association of Apolipoprotein A5 Gene Polymorphisms with Metabolic Syndrome in the Korean Population. Genet. Test Mol. Biomarkers 20, 130-136 (2016).
11. Grallert, H. et al. APOA5 variants and metabolic syndrome in Caucasians. J. Lipid Res. 48, 2614-2621 (2007).
12. Niculescu, L. S., Vlidici, M. & Sima, A. V. Association of APOA5 and APOC3 gene polymorphisms with plasma apolipoprotein A5 level in patients with metabolic syndrome. Biochem. Biophys. Res. Commun. 391, 587-591 (2010).
13. Fallah, M. S. et al. The Relation between Metabolic Syndrome Risk Factors and Genetic Variations of Apolipoprotein V in Relation with Serum Triglyceride and HDL-C Level. Arch. Iran Med. 19, 46-50 (2016).
14. Komurcu-Bayrak, E. et al. Gender-modulated impact of apolipoprotein A5 gene (APOA5)-1131T> C and c. 56C> G polymorphisms on lipids, dyslipidemia and metabolic syndrome in Turkish adults. Clin. Chem. Lab. Med. 46, 778-784 (2008).
15. Mattei, J., Demissie, S., Tucker, K. L. & Ordovas, J. M. Apolipoprotein A5 polymorphisms interact with total dietary fat intake in association with markers of metabolic syndrome in Puerto Rican older adults. J. Nutr. 139, 2301-2308 (2009).
16. Liu, C. F., Yang, Q. F., Chen, X. L. & Liu, C. Y. Apolipoprotein a5 gene polymorphism and risk for metabolic syndrome: A metaanalysis. Genet. Test Mol. Biomarkers 16, 1241-1245 (2012).
17. Peden, J. F. et al. A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease. Nat. Genet. 43, 339-344 (2011).
18. Schunkert, H. et al. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat. Genet. 43, 333-338 (2011).
19. Vargas-Alarcón, G. et al. Single nucleotide polymorphisms within LIPA (Lysosomal Acid Lipase A) gene are associated with susceptibility to premature coronary artery disease. A replication in the genetic of atherosclerotic disease (GEA) Mexican study. PLoS One 8, e74703 (2013).
20. Wang, Y. et al. Genetic variants associated with myocardial infarction and the risk factors in Chinese population. PLoS One 9, e86332 (2014).
21. Kraja, A. T. et al. A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium. Diabetes 60, 1329-1339 (2011).
22. Avery, C. L. et al. A phenomics-based strategy identifies loci on APOC1, BRAP, and PLCG1 associated with metabolic syndrome phenotype domains. PLoS Genet. 7, e1002322 (2011).
23. Kristiansson, K. et al. Genome-wide screen for metabolic syndrome susceptibility Loci reveals strong lipid gene contribution but no evidence for common genetic basis for clustering of metabolic syndrome traits. Circ. Cardiovasc. Genet. 5, 242-249 (2012).
24. Cahua-Pablo, J. Á. et al. Polymorphisms in the LPL and CETP genes and haplotype in the ESR1 gene are associated with metabolic syndrome in women from southwestern Mexico. Int. J. Mol. Sci. 16, 21539-21554 (2015).
25. Braun, T. R. et al. A replication study of GWAS-derived lipid genes in Asian Indians: The chromosomal region 11q23. 3 harbors loci contributing to triglycerides. PLoS One 7, e37056 (2012).
26. Koopal, C. et al. Association between CETP gene polymorphism, insulin resistance and risk of diabetes mellitus in patients with vascular disease. Atherosclerosis 242, 605-610 (2015).
27. Aung, L. H. et al. Association between the MLX interacting protein-like, BUD13 homolog and zinc finger protein 259 gene polymorphisms and serum lipid levels. Sci. Rep. 4, 5565 (2014).
28. Fu, Q. et al. Effects of polymorphisms in APOA4-APOA5-ZNF259-BUD13 gene cluster on plasma levels of triglycerides and risk of coronary heart disease in a Chinese Han population. PLoS One 10, e0138652 (2015).
29. Aung, L. H. et al. Association of the variants in the BUD13-ZNF259 genes and the risk of hyperlipidaemia. J. Cell. Mol. Med. 18, 1417-1428 (2014).
30. Wild, P. S. et al. A genome-wide association study identifies LIPA as a susceptibility gene for coronary artery disease. Circ. Cardiovasc. Genet. 4, 403-412 (2011).
31. Muntoni, S. et al. Heterozygosity for lysosomal acid lipase E8SJM mutation and serum lipid concentrations. Nutr. Metab. Cardiovasc. Dis. 23, 732-736 (2013).
32. Wu, Y. et al. Interactions of Environmental Factors and POA1-APOC3-APOA4-APOA5 Gene Cluster Gene Polymorphisms with Metabolic Syndrome. PLoS One 11, e0147946 (2016).
33. Hiramatsu, M. et al. Synergistic effects of genetic variants of APOA5 and BTN2A1 on dyslipidemia or metabolic syndrome. Int. J. Mol. Med. 30, 185-192 (2012).
34. Son, K. Y. et al. Genetic association of APOA5 and APOE with metabolic syndrome and their interaction with health-related behavior in Korean men. Lipids Health Dis. 14, 105 (2015).
35. Zschenker, O., Illies, T. & Ameis, D. Overexpression of lysosomal acid lipase and other proteins in atherosclerosis. J. Biochem. 140, 23-38 (2006).
36. Merkel, M. et al. Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycanbound lipoprotein lipase. J. Biol. Chem. 280, 21553-21560 (2005).
37. Hsiao, T. J., Hwang, Y., Chang, H. M. & Lin, E. Association of the rs6235 variant in the proprotein convertase subtilisin/kexin type 1 (PCSK1) gene with obesity and related traits in a Taiwanese population. Gene 533, 32-37 (2014).
38. Hsiao, T. J. & Lin, E. A common rs7903146 variant of the transcription factor 7 like 2 gene is associated with type 2 diabetes mellitus and fasting glucose in a Taiwanese population. Diabetes Metab. (2016).
39. Hsiao, T. J. & Lin, E. Evaluation of the glutamine 27 glutamic acid polymorphism in the adrenoceptor beta 2 surface gene on obesity and metabolic phenotypes in Taiwan. J. Investig. Med. 62, 310-315 (2014).
40. Lane, H. Y., Tsai, G. E. & Lin, E. Assessing gene-gene interactions in pharmacogenomics. Mol. Diagn. Ther. 16, 15-27 (2012).
41. Fan, C. T., Lin, J. C. & Lee, C. H. Taiwan Biobank: A project aiming to aid Taiwan's transition into a biomedical island. Pharmacogenomics 9, 235-246 (2008).
42. Liou, Y. J. et al. Gene-gene interactions of the INSIG1 and INSIG2 in metabolic syndrome in schizophrenic patients treated with atypical antipsychotics. Pharmacogenomics J 12, 54-61 (2012).
43. Hsiao, T. J. & Lin, E. The ENPP1 K121Q polymorphism is associated with type 2 diabetes and related metabolic phenotypes in a Taiwanese population. Mol. Cell Endocrinol. 433, 20-25 (2016).
44. Hsiao, T. J. & Lin, E. The Pro12Ala polymorphism in the peroxisome proliferator-activated receptor gamma (PPARG) gene in relation to obesity and metabolic phenotypes in a Taiwanese population. Endocrine 48, 786-793 (2015).
45. Hsiao, T. J., Hwang, Y., Liu, C. H., Chang, H. M. & Lin E. Association of the C825T polymorphism in the GNB3 gene with obesity and metabolic phenotypes in a Taiwanese population. Genes Nutr. 8, 137-144 (2013).
46. Lou, X. Y. et al. A generalized combinatorial approach for detecting gene-by-gene and gene-by-environment interactions with application to nicotine dependence. Am. J. Hum. Genet. 80, 1125-1137 (2007).